A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19

Physical interactions between viral and host proteins are responsible for almost all aspects of the viral life cycle and the host’s immune response. Studying viral-host protein-protein interactions is thus crucial for identifying strategies for treatment and prevention of viral infection. Here, we use high-throughput yeast two-hybrid and affinity purification followed by mass spectrometry to generate a comprehensive SARS-CoV-2-human protein-protein interactome network consisting of both binary and co-complex interactions. We report a total of 739 high-confidence interactions, showing the highest overlap of interaction partners among published datasets as well as the highest overlap with genes differentially expressed in samples (such as upper airway and bronchial epithelial cells) from patients with SARS-CoV-2 infection. Showcasing the utility of our network, we describe a novel interaction between the viral accessory protein ORF3a and the host zinc finger transcription factor ZNF579 to illustrate a SARS-CoV-2 factor mediating a direct impact on host transcription. Leveraging our interactome, we performed network-based drug screens for over 2,900 FDA-approved/investigational drugs and obtained a curated list of 23 drugs that had significant network proximities to SARS-CoV-2 host factors, one of which, carvedilol, showed promising antiviral properties. We performed electronic health record-based validation using two independent large-scale, longitudinal COVID-19 patient databases and found that carvedilol usage was associated with a significantly lowered probability (17%−20%, P < 0.001) of obtaining a SARS-CoV-2 positive test after adjusting various confounding factors. Carvedilol additionally showed anti-viral activity against SARS-CoV-2 in a human lung epithelial cell line [half maximal effective concentration (EC50) value of 4.1 μM], suggesting a mechanism for its beneficial effect in COVID-19. Our study demonstrates the value of large-scale network systems biology approaches for extracting biological insight from complex biological processes.

[1]  Eurie L. Hong,et al.  Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects , 2022, Nature Genetics.

[2]  Jiao Wei,et al.  Review of Ribosome Interactions with SARS-CoV-2 and COVID-19 mRNA Vaccine , 2022, Life.

[3]  M. Mondelli,et al.  Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients , 2021, Genes and immunity.

[4]  F. Cheng,et al.  Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease , 2021, Nature Aging.

[5]  Steven B. Bradfute,et al.  Mammalian hybrid pre-autophagosomal structure HyPAS generates autophagosomes , 2021, Cell.

[6]  Rong Wang,et al.  ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling via Elevating Suppressor of Cytokine Signaling 1 , 2021, Frontiers in Microbiology.

[7]  Lipika R. Pal,et al.  Synthetic lethality-based prediction of anti-SARS-CoV-2 targets , 2021, bioRxiv.

[8]  V. Fuster,et al.  Metoprolol in Critically Ill Patients With COVID-19 , 2021, Journal of the American College of Cardiology.

[9]  Man-man Su,et al.  The Molecular Mechanism of Multiple Organ Dysfunction and Targeted Intervention of COVID-19 Based on Time-Order Transcriptomic Analysis , 2021, Frontiers in immunology.

[10]  S. Whelan,et al.  SARS-CoV-2 Spreads through Cell-to-Cell Transmission , 2021, bioRxiv.

[11]  Tudor I. Oprea,et al.  A machine learning platform to estimate anti-SARS-CoV-2 activities , 2021, Nature Machine Intelligence.

[12]  Qi Dong,et al.  Unique and complementary suppression of cGAS-STING and RNA sensing- triggered innate immune responses by SARS-CoV-2 proteins , 2021, Signal Transduction and Targeted Therapy.

[13]  Pingping Wang,et al.  COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas , 2021, Cell.

[14]  Nicky Phillips,et al.  The coronavirus is here to stay — here’s what that means , 2021, Nature.

[15]  Lipika R. Pal,et al.  Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets , 2021, bioRxiv.

[16]  Pingping Wang,et al.  COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas , 2021, Cell.

[17]  J. Weissman,et al.  BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2 , 2021, Nature Cell Biology.

[18]  M. Veldhoen,et al.  Endemic SARS-CoV-2 will maintain post-pandemic immunity , 2021, Nature Reviews Immunology.

[19]  S. Ganesh,et al.  SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism , 2020, Viruses.

[20]  A. Schäffer,et al.  Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population , 2020, medRxiv.

[21]  F. Cheng,et al.  The Epidemiological and Mechanistic Understanding of the Neurological Manifestations of COVID-19: A Comprehensive Meta-Analysis and a Network Medicine Observation , 2020, Frontiers in Neuroscience.

[22]  E. Lander,et al.  The SARS-CoV-2 RNA–protein interactome in infected human cells , 2020, Nature Microbiology.

[23]  Zhaohui Zheng,et al.  CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells , 2020, Signal Transduction and Targeted Therapy.

[24]  N. Neff,et al.  Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses , 2020, Nature Communications.

[25]  A. Helenius,et al.  Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity , 2020, Science.

[26]  Miguel Correa Marrero,et al.  Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms , 2020, Science.

[27]  M. Guttman,et al.  SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses , 2020, Cell.

[28]  Vineet D. Menachery,et al.  Evasion of Type I Interferon by SARS-CoV-2 , 2020, Cell Reports.

[29]  Ruth Nussinov,et al.  Artificial intelligence in COVID-19 drug repurposing , 2020, The Lancet Digital Health.

[30]  I. Kohane,et al.  A multidimensional precision medicine approach identifies an autism subtype characterized by dyslipidemia , 2020, Nature Medicine.

[31]  Shuwen Liu,et al.  Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 , 2020, Acta Pharmacologica Sinica.

[32]  Xin Wang,et al.  Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis , 2020, Med.

[33]  R. Stewart,et al.  Large-scale Multi-omic Analysis of COVID-19 Severity , 2020, medRxiv.

[34]  Olga Vitek,et al.  MSstatsTMT: Statistical Detection of Differentially Abundant Proteins in Experiments with Isobaric Labeling and Multiple Mixtures , 2020, Molecular & Cellular Proteomics.

[35]  M. He,et al.  Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development , 2020, Signal Transduction and Targeted Therapy.

[36]  F. Cheng,et al.  A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19 , 2020, ChemRxiv : the preprint server for chemistry.

[37]  S. Cascarina,et al.  A proposed role for the SARS‐CoV‐2 nucleocapsid protein in the formation and regulation of biomolecular condensates , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  Yang Han,et al.  The ORF3a protein of SARS-CoV-2 induces apoptosis in cells , 2020, Cellular & Molecular Immunology.

[39]  M. Mann,et al.  Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV , 2020, Nature.

[40]  James T. Gordy,et al.  The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development , 2020, Journal of Virology.

[41]  F. Cheng,et al.  Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2 , 2020, Journal of proteome research.

[42]  D. Matthews,et al.  Neuropilin-1 is a host factor for SARS-CoV-2 infection , 2020, Science.

[43]  C. Skayem,et al.  Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2 , 2020, The American Journal of the Medical Sciences.

[44]  S. Ciesek,et al.  Proteomics of SARS-CoV-2-infected host cells reveals therapy targets , 2020, Nature.

[45]  R. Schwartz,et al.  Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.

[46]  Shayne D. Wierbowski,et al.  A massively parallel barcoded sequencing pipeline enables generation of the first ORFeome and interactome map for rice , 2020, Proceedings of the National Academy of Sciences.

[47]  Chen Hao-ran,et al.  Potential influence of COVID-19/ACE2 on the female reproductive system , 2020, Molecular human reproduction.

[48]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[49]  Jiajia Xie,et al.  Biochemical characterization of SARS-CoV-2 nucleocapsid protein , 2020, Biochemical and Biophysical Research Communications.

[50]  Hans Clevers,et al.  SARS-CoV-2 productively infects human gut enterocytes , 2020, Science.

[51]  Huanhuan Gao,et al.  Proteomic and Metabolomic Characterization of COVID-19 Patient Sera , 2020, Cell.

[52]  David Shum,et al.  Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs , 2020, Antimicrobial Agents and Chemotherapy.

[53]  F. Cheng,et al.  Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 , 2020, Cell Discovery.

[54]  R. Scheuermann,et al.  A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 , 2020, Cell Host & Microbe.

[55]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[56]  H. Shan,et al.  Evidence for Gastrointestinal Infection of SARS-CoV-2 , 2020, Gastroenterology.

[57]  Denisa Bojkova,et al.  Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China , 2020, The New England journal of medicine.

[58]  R. Yusof,et al.  Endoplasmic reticulum: a focal point of Zika virus infection , 2020, Journal of Biomedical Science.

[59]  B. Sitek,et al.  A systematic comparison of label-free, SILAC and TMT techniques to study early adaption towards inhibition of EGFR signaling in the colorectal cancer cell line Difi. , 2019, Journal of proteome research.

[60]  Yoann G. Santin,et al.  Uncovering the In Vivo Proxisome Using Proximity‐Tagging Methods , 2019, BioEssays : news and reviews in molecular, cellular and developmental biology.

[61]  Shayne D. Wierbowski,et al.  Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations , 2019, Nature Communications.

[62]  M. Vidal,et al.  A genome-wide positioning systems network algorithm for in silico drug repurposing , 2019, Nature Communications.

[63]  F. Cheng,et al.  Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer. , 2019, American journal of human genetics.

[64]  Albert-László Barabási,et al.  Network-based prediction of drug combinations , 2019, Nature Communications.

[65]  J. Contessa,et al.  Targeting STT3A‐oligosaccharyltransferase with NGI‐1 causes herpes simplex virus 1 dysfunction , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[66]  S. Gygi,et al.  Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin. , 2019, Analytical chemistry.

[67]  Kara Dolinski,et al.  The BioGRID interaction database: 2019 update , 2018, Nucleic Acids Res..

[68]  Albert-László Barabási,et al.  Network-based approach to prediction and population-based validation of in silico drug repurposing , 2018, Nature Communications.

[69]  Jiro Wada,et al.  MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells , 2018, PloS one.

[70]  J. Michael Cherry,et al.  The Encyclopedia of DNA elements (ENCODE): data portal update , 2017, Nucleic Acids Res..

[71]  Aidan Budd,et al.  SignaLink: Multilayered Regulatory Networks. , 2018, Methods in molecular biology.

[72]  J. Carette,et al.  A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity. , 2017, Cell reports.

[73]  Wei-Guo Zhu,et al.  Linker Histone in Diseases , 2017, International journal of biological sciences.

[74]  R. Zimmermann,et al.  Let’s talk about Secs: Sec61, Sec62 and Sec63 in signal transduction, oncology and personalized medicine , 2017, Signal Transduction and Targeted Therapy.

[75]  Huanchun Chen,et al.  HIST1H1C Regulates Interferon-β and Inhibits Influenza Virus Replication by Interacting with IRF3 , 2017, Front. Immunol..

[76]  Zhongming Zhao,et al.  Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis , 2016, PLoS Comput. Biol..

[77]  Joshua E. Elias,et al.  Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens , 2016, Nature.

[78]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[79]  V. Hornung,et al.  MOV10 Provides Antiviral Activity against RNA Viruses by Enhancing RIG-I–MAVS-Independent IFN Induction , 2016, The Journal of Immunology.

[80]  Albert-László Barabási,et al.  An inter‐species protein–protein interaction network across vast evolutionary distance , 2016, Molecular systems biology.

[81]  N. Krogan,et al.  Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection. , 2016, Immunity.

[82]  Minoru Yoshida,et al.  A Proteome-wide Fission Yeast Interactome Reveals Network Evolution Principles from Yeasts to Human , 2016, Cell.

[83]  Feng Xu,et al.  Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information , 2015, Nucleic Acids Res..

[84]  Eva Harris,et al.  Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination , 2015, Science Translational Medicine.

[85]  Seesandra Venkatappa Rajagopala,et al.  Mapping the Protein–Protein Interactome Networks Using Yeast Two-Hybrid Screens , 2015, Advances in experimental medicine and biology.

[86]  Edward L. Huttlin,et al.  The BioPlex Network: A Systematic Exploration of the Human Interactome , 2015, Cell.

[87]  Chun Jimmie Ye,et al.  A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks , 2015, Cell.

[88]  M. Clerici,et al.  Evolutionary insights into host–pathogen interactions from mammalian sequence data , 2015, Nature Reviews Genetics.

[89]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[90]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[91]  Bin Zhang,et al.  PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..

[92]  Bridget E. Begg,et al.  A Proteome-Scale Map of the Human Interactome Network , 2014, Cell.

[93]  Jilly F. Evans,et al.  Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity. , 2014, Cellular signalling.

[94]  Zhongming Zhao,et al.  Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome. , 2014, Molecular biology and evolution.

[95]  Julie Dyall,et al.  Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection , 2014, Antimicrobial Agents and Chemotherapy.

[96]  Zhongming Zhao,et al.  Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy , 2014, Oncotarget.

[97]  B. Sitek,et al.  Comparison of label-free and label-based strategies for proteome analysis of hepatoma cell lines. , 2014, Biochimica et biophysica acta.

[98]  Joanna L. Sharman,et al.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands , 2013, Nucleic Acids Res..

[99]  Rafael C. Jimenez,et al.  The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases , 2013, Nucleic Acids Res..

[100]  David S. Wishart,et al.  DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..

[101]  Jin Zhang,et al.  PhosphoNetworks: a database for human phosphorylation networks , 2014, Bioinform..

[102]  Kathryn L. Schornberg,et al.  FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection , 2013, Science Translational Medicine.

[103]  Haiyuan Yu,et al.  INstruct: a database of high-quality 3D structurally resolved protein interactome networks , 2013, Bioinform..

[104]  Minoru Yoshida,et al.  Cross-Species Protein Interactome Mapping Reveals Species-Specific Wiring of Stress Response Pathways , 2013, Science Signaling.

[105]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[106]  N. Araki,et al.  Epiplakin modifies the motility of the HeLa cells and accumulates at the outer surfaces of 3‐D cell clusters , 2013, The Journal of dermatology.

[107]  Hsien-Da Huang,et al.  dbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modifications , 2012, Nucleic Acids Res..

[108]  Karin Breuer,et al.  InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation , 2012, Nucleic Acids Res..

[109]  Greg W. Clark,et al.  Coevolution Reveals a Network of Human Proteins Originating with Multicellularity , 2012, Molecular biology and evolution.

[110]  Saliha Durmus Tekir,et al.  Systems biology of pathogen-host interaction: Networks of protein-protein interaction within pathogens and pathogen-human interactions in the post-genomic era , 2013 .

[111]  R. Altman,et al.  Pharmacogenomics Knowledge for Personalized Medicine , 2012, Clinical pharmacology and therapeutics.

[112]  A. Gingras,et al.  Beyond hairballs: The use of quantitative mass spectrometry data to understand protein–protein interactions , 2012, FEBS letters.

[113]  John D. Scott,et al.  Anchoring Proteins as Regulators of Signaling Pathways , 2012, Circulation research.

[114]  James T. Webber,et al.  Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins - eScholarship , 2012 .

[115]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[116]  Rachel M. Adams,et al.  Systematic comparison of label-free, metabolic labeling, and isobaric chemical labeling for quantitative proteomics on LTQ Orbitrap Velos. , 2012, Journal of proteome research.

[117]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2012 update , 2011, Nucleic Acids Res..

[118]  Jianmin Wu,et al.  PINA v2.0: mining interactome modules , 2011, Nucleic Acids Res..

[119]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[120]  Matko Bosnjak,et al.  REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms , 2011, PloS one.

[121]  Stephen S. Gisselbrecht,et al.  Deficiency of the cytoskeletal protein SPECC1L leads to oblique facial clefting. , 2011, American journal of human genetics.

[122]  Cathryn M. Gould,et al.  Phospho.ELM: a database of phosphorylation sites—update 2011 , 2010, Nucleic acids research.

[123]  R. Dean,et al.  Direct comparison of stable isotope labeling by amino acids in cell culture and spectral counting for quantitative proteomics. , 2010, Analytical chemistry.

[124]  Richard A. Moore,et al.  The Completion of the Mammalian Gene Collection (mgc) Recommended Citation , 2022 .

[125]  A. Noegel,et al.  Structural and functional diversity of novel coronin 1C (CRN2) isoforms in muscle. , 2009, Journal of molecular biology.

[126]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[127]  C. Ruiz-Cañada,et al.  Cotranslational and Posttranslational N-Glycosylation of Polypeptides by Distinct Mammalian OST Isoforms , 2009, Cell.

[128]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[129]  A. Barabasi,et al.  High-Quality Binary Protein Interaction Map of the Yeast Interactome Network , 2008, Science.

[130]  L. Schang,et al.  Linker Histones Are Mobilized during Infection with Herpes Simplex Virus Type 1 , 2008, Journal of Virology.

[131]  H. Christofk,et al.  A label‐free quantification method by MS/MS TIC compared to SILAC and spectral counting in a proteomics screen , 2008, Proteomics.

[132]  Allegra Via,et al.  Phospho.ELM: a database of phosphorylation sites—update 2008 , 2007, Nucleic Acids Res..

[133]  L. Werling,et al.  A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: Treatment of involuntary emotional expression disorder , 2007, Experimental Neurology.

[134]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[135]  D. Kelleher,et al.  An evolving view of the eukaryotic oligosaccharyltransferase. , 2006, Glycobiology.

[136]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[137]  A. E. Hirsh,et al.  Adjusting for selection on synonymous sites in estimates of evolutionary distance. , 2005, Molecular biology and evolution.

[138]  Shing‐Jong Lin,et al.  Carvedilol Inhibits Tumor Necrosis Factor-&agr;–Induced Endothelial Transcription Factor Activation, Adhesion Molecule Expression, and Adhesiveness to Human Mononuclear Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[139]  B. Causier.  Studying the interactome with the yeast two-hybrid system and mass spectrometry. , 2004, Mass spectrometry reviews.

[140]  A. Travers,et al.  The role of histone H1 in chromatin condensation and transcriptional repression , 2004, Genetica.

[141]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[142]  Hisashi Moriguchi,et al.  Treatment of SARS with human interferons , 2003, The Lancet.

[143]  J. Bonifacino,et al.  Stonin 2: an adaptor-like protein that interacts with components of the endocytic machinery. , 2001 .

[144]  S. Carr,et al.  Overview of peptide and protein analysis by mass spectrometry. , 2001, Current protocols in protein science.

[145]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[146]  C. Rice,et al.  trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication , 1997, Journal of virology.